EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update.

Moseng, Tuva; Vliet Vlieland, Theodora P M; Battista, Simone; Beckwée, David; Boyadzhieva, Vladimira; Conaghan, Philip G; Costa, Daniela; Doherty, Michael; Finney, Andrew G; Georgiev, Tsvetoslav; Gobbo, Milena; Kennedy, Norelee; Kjeken, Ingvild; Kroon, Féline P B; Lohmander, L Stefan; Lund, Hans; Mallen, Christian D; Pavelka, Karel; Pitsillidou, Irene A; Rayman, Margaret P; Tveter, Anne Therese; Vriezekolk, Johanna E; Wiek, Dieter; Zanoli, Gustavo; Østerås, Nina

doi:10.1136/ard-2023-225041

All Outputs (2)

306 Barriers and enablers to the implementation of osteoarthritis management programmes in primary or community care settings: a systematic review and qualitative framework synthesis (2024)
Presentation / Conference
Cunningham, J. C., Briggs, A. M., Cottrell, E., Doyle, F., Dziedzic, K., Finney, A., …French, H. (2024, April). 306 Barriers and enablers to the implementation of osteoarthritis management programmes in primary or community care settings: a systematic review and qualitative framework synthesis. Poster presented at 2024 OARSI World Congress on Osteoarthritis, Vienna, Austria

EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update. (2024)
Journal Article
Moseng, T., Vliet Vlieland, T. P. M., Battista, S., Beckwée, D., Boyadzhieva, V., Conaghan, P. G., …Østerås, N. (in press). EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update. Annals of the Rheumatic Diseases, https://doi.org/10.1136/ard-2023-225041

Hip and knee osteoarthritis (OA) are increasingly common with a significant impact on individuals and society. Non-pharmacological treatments are considered essential to reduce pain and improve function and quality of life. EULAR recommendations for... Read More about EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update..